A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
I-Mab Biopharma US Limited
I-Mab Biopharma US Limited
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NRG Oncology
Hoffmann-La Roche
Massachusetts General Hospital
Hoffmann-La Roche
Revolution Medicines, Inc.
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center